Big Move For Kindred Biosciences, Inc.
Wed, Jun 16, 2021 at 05:30 PM
Kindred Biosciences, Inc. (KIN:NASDAQ) jumped higher at $9.23, representing a gain of 45.6%. The stock got featured on our News Catalysts scanner on Wed, Jun 16, 2021 at 04:30 PM in the 'ACQUISITION' category. From Tue, Jun 01, 2021, the stock recorded 60.00% Up Days and 54.55% Green Days
About Kindred Biosciences, Inc. (KIN:NASDAQ)
Kindred Biosciences Inc is a development-stage biopharmaceutical company. It is engaged in saving and improving the lives of pets. The Company's product candidates are SentiKind, KIND-010 and KIND-012.
Top 10 Gainers:
- ORPH (ORPH:NASDAQ), 61.29%
- Kindred Biosciences, Inc. (KIN:NASDAQ), 45.58%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 21.45%
- UTME (UTME:NASDAQ), 20.41%
- GTT Communications, Inc. (GTT:NYSE), 20%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 18.95%
- Torchlight Energy Resources, Inc. (TRCH:NASDAQ), 18.15%
- OPT (OPT:NASDAQ), 17.48%
- AUVI (AUVI:NASDAQ), 17.39%
- Altimmune, Inc. (ALT:NASDAQ), 16.49%